AstraZeneca (AZN)

Add to Watchlists
Create an Alert
28.50 +0.03  +0.11% NYSE Jan 18, 20:00 Delayed 2m USD

AstraZeneca Enterprise Value:

87.62B for Jan. 18, 2017
View 4,000+ financial data types
Browse...
View Full Chart

AstraZeneca Enterprise Value Chart

Export Data
Save Image
Print Image

AstraZeneca Historical Enterprise Value Data

View and export this data going back to 1994. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Jan. 18, 2017 87.62B
Jan. 17, 2017 87.55B
Jan. 13, 2017 87.82B
Jan. 12, 2017 86.96B
Jan. 11, 2017 86.81B
Jan. 10, 2017 88.25B
Jan. 9, 2017 87.70B
Jan. 6, 2017 87.44B
Jan. 5, 2017 88.10B
Jan. 4, 2017 86.18B
Jan. 3, 2017 85.62B
Dec. 30, 2016 84.64B
Dec. 29, 2016 84.74B
Dec. 28, 2016 84.36B
Dec. 27, 2016 84.48B
Dec. 23, 2016 84.61B
Dec. 22, 2016 84.28B
Dec. 21, 2016 83.98B
Dec. 20, 2016 83.88B
Dec. 19, 2016 83.70B
Dec. 16, 2016 86.00B
Dec. 15, 2016 85.60B
Dec. 14, 2016 84.56B
Dec. 13, 2016 85.60B
Dec. 12, 2016 83.67B
   
Dec. 9, 2016 84.23B
Dec. 8, 2016 81.98B
Dec. 7, 2016 80.92B
Dec. 6, 2016 81.32B
Dec. 5, 2016 80.84B
Dec. 2, 2016 81.02B
Dec. 1, 2016 80.82B
Nov. 30, 2016 81.65B
Nov. 29, 2016 83.09B
Nov. 28, 2016 83.14B
Nov. 25, 2016 84.08B
Nov. 23, 2016 82.23B
Nov. 22, 2016 82.38B
Nov. 21, 2016 84.69B
Nov. 18, 2016 84.13B
Nov. 17, 2016 84.71B
Nov. 16, 2016 84.84B
Nov. 15, 2016 85.42B
Nov. 14, 2016 85.47B
Nov. 11, 2016 86.31B
Nov. 10, 2016 85.55B
Nov. 9, 2016 88.76B
Nov. 8, 2016 86.33B
Nov. 7, 2016 86.08B
Nov. 4, 2016 85.50B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

AZN Enterprise Value Benchmarks

Companies
GlaxoSmithKline 118.76B
Bristol-Myers Squibb 95.14B
Eli Lilly 90.74B

AZN Enterprise Value Range, Past 5 Years

Minimum 50.61B Jun 05 2012
Maximum 107.46B May 01 2014
Average 79.69B

AZN Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("AZN", "enterprise_value")
  • Last 5 data points: =YCS("AZN", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.